Deletion of Kdm5d sensitized cancer cells to CD8+ T cell‐mediated killing, while Kdm5d overexpression diminished CD8+ T cell infiltration at the tumor invasive front, mimicking the effect of KRAS mutation. The gene discussed is KDM5D; the disease is cancer.